BEIJING, April 7 (Xinhua) -- China's advantages in manufacturing stand out again when the country satisfies the world's demands for ventilators in time amid global efforts to fight against the COVID-19, reported Securities Daily Tuesday.
Facing difficulties in mass production of ventilators such as production line rebuilding, technical barriers, parts supply, quality supervision and approval aimd the epidemic, multiple countries have turned their eyes to China, said the report.
Why China, where large and high-end medical ventilators still rely on import, can play a major role in expanding the production of ventilators in the global epidemic?
Data showed that only three of the top ten ventilator brands in China are China's domestic brands in 2019. However, it was China's ventilator companies that responded quickly to expand production after the epidemic outbreak.
According to China's Ministry of Industry and Information Technology, the country had manufactured over 15,000 ventilators in February this year, far exceeding the full year of 2018 which recorded 8,400.
Data from Getinge, one of the world's top ten ventilator manufacturers, showed that the company's ventilator output was just 10,000 in 2019.
Inferior to international brands of high-end medical ventilators, China's industrial chain and supply chain have taken an absolute advantage at the critical moment, helping the country act quickly in building production lines and deploying production marterials and labor force.
"In the global division of labor, Chinese manufacturing is a very important link which boasts very high value in the whole industrial chain despite of the relatively low gross margin in the manufacturing link," said Hua Li, deputy director of investment with Shenzhen EFUNG Investment Management Enterprise L. P., a Chinese company focusing on biomedical investment.
Besides, most of the production bases of foreign brands are in China, and the lack of production lines caused by high labor cost and the absence of related supply chains determine that the Europe and America are uncapable of trasforming the production lines quickly to meet urgent needs.
"Behind this is China's ability to respond to crisis and mobilize and organize the whole society. The advantages of Chinese manufacturing are obvious," said Ji Changtao, director of investment with Huada Win-win (Shenzhen) Equity Investment Fund Management Co., Ltd., a company in sourthern China.
The report also noted that driven by the strong supply chain, China's medical device industry is developing rapidly. China's medical device market is expected to exceed 700 billion yuan in 2020. (Edited by Gu Shanshan with Xinhua Silk Road, gushanshan.1987@163.com)
A single purchase
